Total metabolic tumor volume by 18F-FDG PET/CT for the prediction of outcome in patients with non-small cell lung cancer

S Pellegrino, R Fonti, E Mazziotti, L Piccin… - Annals of Nuclear …, 2019 - Springer
Objective Metabolic tumor volume (MTV) and total lesion glycolysis (TLG) are imaging
parameters derived from 18F-FDG PET/CT that have been proposed for risk stratification of …

Prognostic value of volumetric parameters on staging and posttreatment FDG PET/CT in patients with stage IV non–small cell lung cancer

JW Lee, SM Lee, M Yun, A Cho - Clinical nuclear medicine, 2016 - journals.lww.com
Purpose This study aimed to evaluate the prognostic value of metabolic tumor burden as
measured with metabolic tumor volume (MTV) and total lesion glycolysis (TLG), as well as …

Metabolic tumor volume measured by F-18 FDG PET/CT can further stratify the prognosis of patients with stage IV non-small cell lung cancer

SW Yoo, J Kim, A Chong, SY Kwon, JJ Min… - Nuclear medicine and …, 2012 - Springer
Purpose This study aimed to further stratify prognostic factors in patients with stage IV non-
small cell lung cancer (NSCLC) by measuring their metabolic tumor volume (MTV) using F …

Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer

K Kim, SJ Kim, IJ Kim, YS Kim, K Pak… - Nuclear medicine …, 2012 - journals.lww.com
Objectives The aim of this study was to evaluate the usefulness of the tumor burden as
characterized by the metabolic tumor volume (MTV) and total lesion glycolysis (TLG) …

Independent prognostic value of whole-body metabolic tumor burden from FDG-PET in non-small cell lung cancer

H Zhang, K Wroblewski, D Appelbaum, Y Pu - International journal of …, 2013 - Springer
Purpose To determine whether whole-body metabolic tumor burden, measured as either
metabolic tumor volume (MTV WB) or total lesion glycolysis (TLG WB), using FDG-PET/CT is …

Prognostic value of volumetric parameters of 18F-FDG PET in non-small-cell lung cancer: a meta-analysis

HJ Im, K Pak, GJ Cheon, KW Kang, SJ Kim… - European journal of …, 2015 - Springer
Purpose We conducted a comprehensive systematic review of the literature on volumetric
parameters from 18 F-FDG PET and a meta-analysis of the prognostic value of metabolic …

Volume-based assessment by 18F-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer

SH Hyun, HK Ahn, H Kim, MJ Ahn, K Park… - European journal of …, 2014 - Springer
Purpose We evaluated the prognostic impact of volume-based assessment by 18 F-FDG
PET/CT in patients with stage III non-small-cell lung cancer (NSCLC). Methods We reviewed …

Prognostic value of metabolic tumor burden from 18F-FDG PET in surgical patients with non–small-cell lung cancer

H Zhang, K Wroblewski, S Liao, R Kampalath… - Academic radiology, 2013 - Elsevier
OBJECTIVE: To assess the prognostic value of metabolic tumor burden as measured with
metabolic tumor volume (MTV) and total lesion glycolysis (TLG) on 2-deoxy-2-(18F) fluoro-D …

Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer

S Liao, BC Penney, K Wroblewski, H Zhang… - European journal of …, 2012 - Springer
Purpose The objective of this study was to assess the prognostic value of metabolic tumor
burden on 2-deoxy-2-[18 F] fluoro-D-glucose (18 F-FDG) positron emission tomography …

Measurement of tumor volume by PET to evaluate prognosis in patients with advanced non-small cell lung cancer treated by non-surgical therapy

H Yan, R Wang, F Zhao, K Zhu, S Jiang… - Acta …, 2011 - journals.sagepub.com
Background Patients with advanced non-small cell lung cancer (NSCLC) seem to have
disparity in prognosis. Accurate prediction of prognosis could be useful in the future to …